Study Shows Financial Services Organizations’ Push Towards Hybrid Cloud Model is Built On Private Cloud Investments

Study Shows Financial Services Organizations’ Push Towards Hybrid Cloud Model is Built On Private Cloud Investments

43% of Financial Services Companies Globally Plan to Increase Their Investment in Private Cloud Over the Next Year

SAN JOSE, Calif.–(BUSINESS WIRE)–Nutanix (NASDAQ: NTNX), a leader in private cloud, hybrid and multicloud computing, today announced the financial services industry findings of its third annual Enterprise Cloud Index Report, measuring organizations’ plans for adopting private, hybrid and public clouds. The findings point to a digital transformation within the industry, with half of respondents (50%) reporting that COVID-19 caused them to increase their investment in hybrid cloud.

In the industry’s five-year outlook, hybrid cloud is the only IT model showing positive growth among financial company respondents, and it is expected to increase by 39% in that timeframe. In addition, 43% of financial services companies plan to increase their investment in private cloud over the next year, 10% higher than the global average (33%) – pinpointing that private cloud adoption is crucial to creating a modern hybrid cloud.

Other key findings of this year’s report include:

  • Security concerns are driving private cloud adoption: Financial services organizations ranked security, privacy, and compliance issues as the most concerning when running applications within public cloud solutions (62%). Respondents were less concerned with public cloud capacity (30%), showing that while public cloud has the capabilities to support IT infrastructures, the security of sensitive data is non-negotiable, and organizations are looking for alternative solutions.
  • Investment in hyperconverged infrastructure shows the industry’s confidence in private cloud: Nearly 50% of financial sector respondents say they’ve either fully deployed HCI or are in the process of doing so, while 38% report they will be deploying HCI within the next 12 to 24 months. This investment is directly aligned with increased private cloud adoption, as HCI reduces the time it takes to build the software-defined, scalable infrastructure necessary to support private cloud.
  • Financial services organizations are looking to optimize their cloud usage: The sector’s top motivations for modernizing its IT infrastructure is to gain greater control of IT resource usage (59%) and to gain the speed (58%), and flexibility needed (55%) to meet business requirements.
  • The industry must invest in talent to support a hybrid cloud environment: More than a third of financial services respondents (36%) said they were short on skills needed to manage mixed private/public cloud environments, while 34% said they lacked expertise in cloud-native technologies and containers, including Kubernetes. These issues have contributed to organizational struggles to fully adopt hybrid cloud.

“Historically, financial services organizations have explored public cloud offerings when decommissioning legacy datacenters,” said Tapan Mehta, Director, Industries Solution Marketing at Nutanix. “However, as the industry continues to place greater interest in data privacy and compliance issues, organizations are turning to the private cloud. This rapid increase in private cloud adoption serves as the basis for a hybrid cloud model, which is expected to become the industry norm over the next few years.”

The 2020 respondent base spanned multiple industries, business sizes, and the following geographies: the Americas; Europe, the Middle East, and Africa (EMEA); and the Asia-Pacific (APJ) region.

To learn more about the financial services findings, please download the report here.

About Nutanix

Nutanix is a global leader in cloud software and a pioneer in hyperconverged infrastructure solutions, making computing invisible anywhere. Organizations around the world use Nutanix software to leverage a single platform to manage any app at any location at any scale for their private, hybrid and multi-cloud environments. Learn more at www.nutanix.com or follow us on Twitter @nutanix.

© 2021 Nutanix, Inc. All rights reserved. Nutanix, the Nutanix logo and all Nutanix product and service names mentioned herein are registered trademarks or trademarks of Nutanix, Inc. in the United States and other countries. Other brand names mentioned herein are for identification purposes only and may be the trademarks of their respective holder(s). This release may contain links to external websites that are not part of Nutanix.com. Nutanix does not control these sites and disclaims all responsibility for the content or accuracy of any external site. Our decision to link to an external site should not be considered an endorsement of any content on such a site. Certain information contained in this press release may relate to or be based on studies, publications, surveys and other data obtained from third-party sources and our own internal estimates and research. While we believe these third-party studies, publications, surveys and other data are reliable as of the date of this press release, they have not independently verified, and we make no representation as to the adequacy, fairness, accuracy, or completeness of any information obtained from third-party sources.

This release may contain express and implied forward-looking statements, which are not historical facts and are instead based on our current expectations, estimates and beliefs. The accuracy of such statements involves risks and uncertainties and depends upon future events, including those that may be beyond our control, and actual results may differ materially and adversely from those anticipated or implied by such statements. Any forward-looking statements included herein speak only as of the date hereof and, except as required by law, we assume no obligation to update or otherwise revise any of such forward-looking statements to reflect subsequent events or circumstances.

Nutanix

Lia Bigano

(408) 708-1003, Extension – 12636

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Data Management Banking Accounting Technology Professional Services Security Software Other Professional Services Networks Internet Finance

MEDIA:

L3Harris Technologies Demonstrates Antenna Technology for US Space Force Satellite Communications

L3Harris Technologies Demonstrates Antenna Technology for US Space Force Satellite Communications

Highlights:

  • Integrates advanced antenna solution with legacy U.S. Air Force Satellite Control Network
  • Confirms live contacts with DOD satellites for downlink, uplink and orbital ranging
  • Leverages L3Harris’ proven technology in designing and building space systems

MELBOURNE, Fla.–(BUSINESS WIRE)–
L3Harris Technologies (NYSE:LHX) has successfully completed a technology demonstration, under a Defense Innovation Unit prototype contract, for the U.S. Space Force satellite communication system to improve communications with the agency’s growing number of satellites.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210112005106/en/

L3Harris developed a Multi-Band Multi-Mission (MBMM) phased array ground antenna system and integrated it with the Space Force’s Satellite Communication Network system in order to demonstrate multiple simultaneous satellite contacts. (Graphic: Business Wire)

L3Harris developed a Multi-Band Multi-Mission (MBMM) phased array ground antenna system and integrated it with the Space Force’s Satellite Communication Network system in order to demonstrate multiple simultaneous satellite contacts. (Graphic: Business Wire)

L3Harris developed a Multi-Band Multi-Mission (MBMM) phased array ground antenna system and integrated it with the Space Force’s Satellite Communication Network system in order to demonstrate multiple simultaneous satellite contacts. Traditional parabolic or radio antennas can contact only one satellite at a time.

The MBMM system’s all-digital architecture established 16 simultaneous contacts during the demonstration. The system can scale up to support hundreds of concurrent satellite connections from a single phased array antenna system, reducing the physical footprint needed for ground antennas and lowering the infrastructure cost per satellite contact.

“L3Harris developed an all-digital phased array antenna technology to meet the enormous ground system capacity demands created by the increasing number of satellite missions,” said Ed Zoiss, President, Space and Airborne Systems, L3Harris. “This successful demonstration from L3Harris readies our nation with a capable and affordable advanced satellite communications approach today for the further proliferation of satellites in the near future.”

The L3Harris demonstration successfully confirmed live contacts with Space Force satellites across multiple orbital regimes at Schriever Air Force Base in Colorado.

“The MBMM demonstrations were a complete success that showcased the advancements in phased array technology and relevance for satellite command and control with live DOD systems. It has reinvigorated interest in the MBMM program as a key part of the overall space architecture,” said Col. Wallace “Rhett” Turnbull III, Director, Cross Mission Ground and Communications Enterprise, Space and Missile Systems Center. “Capabilities like those recently demonstrated may play an important role in meeting the growing demand for satellite control capacity by providing more affordable and resilient access to Space Force satellite systems.”

L3Harris performed the successful demonstration with support from Kratos Defense & Security Solutions, Inc. and Mercury Systems.

About L3Harris Technologies

L3Harris Technologies is an agile global aerospace and defense technology innovator, delivering end-to-end solutions that meet customers’ mission-critical needs. The company provides advanced defense and commercial technologies across air, land, sea, space and cyber domains. L3Harris has approximately $18 billion in annual revenue and 48,000 employees, with customers in more than 100 countries. L3Harris.com.

Forward-Looking Statements

This press release contains forward-looking statements that reflect management’s current expectations, assumptions and estimates of future performance and economic conditions. Such statements are made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The company cautions investors that any forward-looking statements are subject to risks and uncertainties that may cause actual results and future trends to differ materially from those matters expressed in or implied by such forward-looking statements. Statements about system capabilities are forward-looking and involve risks and uncertainties. L3Harris disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Irene Lockwood

Space and Airborne Systems

[email protected]

585-465-3592

Sara Banda

Corporate

[email protected]

321-674-4498

KEYWORDS: Florida United States North America

INDUSTRY KEYWORDS: Engineering Defense Satellite Technology Aerospace Manufacturing Other Defense

MEDIA:

Logo
Logo
Photo
Photo
L3Harris developed a Multi-Band Multi-Mission (MBMM) phased array ground antenna system and integrated it with the Space Force’s Satellite Communication Network system in order to demonstrate multiple simultaneous satellite contacts. (Graphic: Business Wire)

Cabot Corporation Announces Retirement of Mark Wrighton from Board of Directors

Cabot Corporation Announces Retirement of Mark Wrighton from Board of Directors

BOSTON–(BUSINESS WIRE)–Cabot Corporation (NYSE: CBT) announced the upcoming retirement of Mark S. Wrighton from its Board of Directors. Mr. Wrighton, who has served as a director of Cabot since 1997, is retiring from the Board when his current term of office expires effective at Cabot’s Annual Meeting of Stockholders to be held on March 11, 2021. He currently serves as a member of the Compensation Committee and during his tenure on Cabot’s Board, Mr. Wrighton has also served on the Board’s Safety, Health, Environment and Sustainability Committee.

“Mark has provided insightful guidance during his tenure on the Cabot Board of Directors,” said Ms. Rataj, Non-Executive Chair of the Board. “We have benefitted greatly from Mark’s extensive scientific knowledge and understanding of complex technology, significant management and leadership experience and deep understanding of matters related to public company management and oversight. On behalf of everyone at Cabot and the Board, I extend our heartfelt gratitude to Mark for his many years of service to the Cabot Board and wish him all the very best.”

ABOUT CABOT CORPORATION

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company is a leading provider of carbon black, specialty carbons, activated carbon, elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed silica and aerogel. For more information on Cabot, please visit the company’s website at cabotcorp.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in the press release regarding Cabot’s business that are not historical facts are forward looking statements that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s Annual Report on Form 10-K.

Vanessa Craigie, Corporate Communications

[email protected]

+1.617.342.6015

Steve Delahunt, Investor Relations

[email protected]

+1.617.342.6255

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Chemicals/Plastics Manufacturing

MEDIA:

Logo
Logo

Bank of America to Report Fourth-Quarter 2020 Financial Results on January 19

Bank of America to Report Fourth-Quarter 2020 Financial Results on January 19

CHARLOTTE, N.C.–(BUSINESS WIRE)–
As previously announced, Bank of America will report its fourth-quarter 2020 financial results on Tuesday, January 19. The results will be released at approximately 6:45 a.m. ET, followed by an investor presentation at 8:30 a.m. ET.

The news release, supplemental filing and investor presentation can be accessed in the following ways:

Investor Conference Call Information

For a listen-only connection to the investor presentation, dial 1.877.200.4456 (U.S.) or 1.785.424.1732 (international). The conference ID is 79795. Please dial in 10 minutes prior to the start of the call. Investors can also listen to a live audio webcast of the conference call and view the presentation slides by visiting the “Events & Presentations” section of the company’s Investor Relations website.

Bank of America

Bank of America is one of the world’s leading financial institutions, serving individual consumers, small and middle-market businesses and large corporations with a full range of banking, investing, asset management and other financial and risk management products and services. The company provides unmatched convenience in the United States, serving approximately 66 million consumer and small business clients with approximately 4,300 retail financial centers, including approximately 2,900 lending centers, 2,500 financial centers with a Consumer Investment Financial Solutions Advisor and approximately 2,300 business centers; approximately 17,000 ATMs; and award-winning digital banking with approximately 39 million active users, including approximately 31 million mobile users. Bank of America is a global leader in wealth management, corporate and investment banking and trading across a broad range of asset classes, serving corporations, governments, institutions and individuals around the world. Bank of America offers industry-leading support to approximately 3 million small business owners through a suite of innovative, easy-to-use online products and services. The company serves clients through operations across the United States, its territories and approximately 35 countries. Bank of America Corporation stock (NYSE: BAC) is listed on the New York Stock Exchange.

For more Bank of America news, including dividend announcements and other important information, visit the Bank of America newsroom and register for email news alerts.

www.bankofamerica.com

Investors May Contact:

Lee McEntire, Bank of America

Phone: 1.980.388.6780

[email protected]

Jonathan G. Blum, Bank of America (Fixed Income)

Phone: 1.212.449.3112

[email protected]

Reporters May Contact:

Jerry Dubrowski, Bank of America

Phone: 1.646.855.1195 (office) or 1.508.843.5626 (mobile)

[email protected]

Christopher P. Feeney, Bank of America

Phone: 1.980.386.6794

[email protected]

KEYWORDS: North Carolina United States North America

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

ACCO Brands Corporation Announces Fourth Quarter and Full Year 2020 Earnings Webcast

ACCO Brands Corporation Announces Fourth Quarter and Full Year 2020 Earnings Webcast

LAKE ZURICH, Ill.–(BUSINESS WIRE)–
ACCO Brands Corporation (NYSE: ACCO) today announced that it will release its fourth quarter and full year 2020 earnings after the market close on February 16, 2021. The Company will host a conference call and webcast to discuss the results on February 17 at 8:30 a.m. EST. The webcast can be accessed through the Investor Relations section of www.accobrands.com and will be available for replay.

About ACCO Brands Corporation

ACCO Brands Corporation (NYSE: ACCO) is one of the world’s largest designers, marketers and manufacturers of branded academic, consumer and business products. Our widely recognized brands include Artline®, AT-A-GLANCE®, Barrilito®, Derwent®, Esselte®, Five Star®, Foroni®, GBC®, Hilroy®, Kensington®, Leitz®, Mead®, PowerA®, Quartet®, Rapid®, Rexel®, Swingline®, Tilibra®, Wilson Jones® and many others. Our products are sold in more than 100 countries around the world. More information about ACCO Brands, the Home of Great Brands Built by Great People, can be found at www.accobrands.com.

Christine Hanneman

Investor Relations

(847) 796-4320

Julie McEwan

Media Relations

(937) 974-8162

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Retail Office Products Other Manufacturing Manufacturing

MEDIA:

Logo
Logo

Royal Gold Presenting at the 24th Annual CIBC Western Institutional Investor Conference

Royal Gold Presenting at the 24th Annual CIBC Western Institutional Investor Conference

DENVER–(BUSINESS WIRE)–Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that management will present virtually at the 24th Annual CIBC Western Institutional Conference.

Bill Heissenbuttel, President and CEO, will participate in a Royalty Panel discussion on Wednesday, January 20, from 4:10 p.m. to 5:15 p.m. ET (1:10 p.m. to 2:15 p.m. PT / 2:10 p.m. to 3:15 p.m. MT). The webcast may be accessed through the Company’s website under the Investors/Events and Presentations page.

Corporate Profile

Royal Gold is a precious metals stream and royalty company engaged in the acquisition and management of precious metal streams, royalties and similar production-based interests. As of December 31, 2020, the Company owned interests on 189 properties on five continents, including interests on 41 producing mines and 17 development stage projects. Royal Gold is publicly traded on the Nasdaq Global Select Market under the symbol “RGLD.” The Company’s website is located at www.royalgold.com.

Alistair Baker

Vice President Investor Relations and Business Development

(720) 554-6995

KEYWORDS: Colorado United States North America Canada

INDUSTRY KEYWORDS: Mining/Minerals Natural Resources

MEDIA:

Logo
Logo

Royal Gold Provides Update on its Fiscal 2021 Second Quarter

Royal Gold Provides Update on its Fiscal 2021 Second Quarter

DENVER–(BUSINESS WIRE)–Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that its wholly owned subsidiary, RGLD Gold AG, sold approximately 57,500 gold equivalent ounces1 (“GEOs”) comprised of approximately 44,500 gold ounces, 461,000 silver ounces and 1,800 tonnes of copper related to its streaming agreements during its fiscal 2021 second quarter ended December 31, 2020 (“second quarter”). Second quarter stream sales were slightly higher than the previous guidance range of 52,000 to 57,000 GEOs. The Company had approximately 29,500 GEOs in inventory at the end of the second quarter consisting of 21,500 gold ounces, 485,000 silver ounces and 400 tonnes of copper. Inventory at the end of the second quarter was higher than the previous guidance range of 23,000 to 28,000 GEOs primarily due to timing of deliveries.

RGLD Gold AG’s average realized gold, silver and copper prices for the second quarter were $1,880 per ounce, $24.16 per ounce, and $6,995 per tonne ($3.17 per pound), respectively, compared to $1,897, $22.97, and $6,494 ($2.95), respectively, in the prior quarter ended September 30, 2020 (“first quarter”). Cost of sales was approximately $432 per GEO for the second quarter using the quarterly average silver-gold ratio of approximately 77 to 1 and copper-gold ratio of approximately 0.26 tonnes per ounce, compared to cost of sales of $389 per GEO in the first quarter. Cost of sales is specific to our streaming agreements and is the result of the Company’s purchase of gold, silver or copper for cash payments at a set contractual price, or a percentage of the prevailing market price of gold, silver or copper when purchased.

Corporate Profile

Royal Gold is a precious metals stream and royalty company engaged in the acquisition and management of precious metal streams, royalties and similar production-based interests. As of December 31, 2020, the Company owned interests on 189 properties on five continents, including interests on 41 producing mines and 17 development stage projects. Royal Gold is publicly traded on the Nasdaq Global Select Market under the symbol “RGLD.” The Company’s website is located at www.royalgold.com.

For further information, please contact:

 

Second Quarter 2021 Call Information:

 

 

 

Alistair Baker

 

Dial-In

855-209-8260 (U.S.); toll free

Vice President Investor Relations and Business

Development

 

Numbers:

855-669-9657 (Canada); toll free

412-542-4106 (International)

(720) 554-6995

 

Conference Title:

Royal Gold

 

 

 

 

Note: Royal Gold’s second quarter results will be released after the market closes on Wednesday, February 3, 2021, followed by a conference call on Thursday, February 4, 2021 at 12:00 p.m. Eastern Time (10:00 a.m. Mountain Time). The call will be webcast and archived on the Company’s website for a limited time.

 

Webcast URL:

www.royalgold.com under Investors, Events & Presentations

 

 

 

 

 

 

Forward-Looking Statements: This press release includes “forward-looking statements” within the meaning of U.S. federal securities laws. Forward-looking statements are any statements other than statements of historical fact. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from these statements. Forward-looking statements are often identified by words like “will,” “may,” “could,” “should,” “would,” “believe,” “estimate,” “expect,” “anticipate,” “plan,” “forecast,” “potential,” “intend,” “continue,” “project,” or negatives of these words or similar expressions. Forward-looking statements include, among others, statements about second quarter operating results. Factors that could cause actual results to differ materially from these forward-looking statements include, among others, the following: a lower-price environment for gold, silver, copper, nickel or other metals; operating activities or financial performance of properties on which we hold stream or royalty interests, including variations between actual and forecasted performance, operators’ ability to complete projects on schedule and as planned, changes to mine plans and reserves, liquidity needs, mining and environmental hazards, labor disputes, distribution and supply chain disruptions, permitting and licensing issues, or contractual issues involving our stream or royalty agreements; risks associated with doing business in foreign countries; our ability to identify, finance, value and complete acquisitions; adverse economic and market conditions; changes in laws or regulations governing us, operators or operating properties; changes in management and key employees; the impacts of the COVID-19 pandemic; and other factors described in our reports filed with the Securities and Exchange Commission, including our Form 10-K for the fiscal year ended June 30, 2020, and subsequent Forms 10-Q. Most of these factors are beyond our ability to predict or control. Forward-looking statements speak only as of the date on which they are made. We disclaim any obligation to update any forward-looking statements, except as required by law. Readers are cautioned not to put undue reliance on forward-looking statements.

  1. Gold equivalent ounces, or GEOs, is calculated by the Company as revenue (in total or by reportable segment) for a period divided by the average gold price for that same period.

 

Alistair Baker

Vice President Investor Relations and Business Development

(720) 554-6995

KEYWORDS: United States North America Canada Colorado

INDUSTRY KEYWORDS: Mining/Minerals Natural Resources

MEDIA:

Logo
Logo

Aspen Technology Appoints David Leitham as Senior Vice President and General Manager to Lead Pharmaceutical Industry Effort

Aspen Technology Appoints David Leitham as Senior Vice President and General Manager to Lead Pharmaceutical Industry Effort

BEDFORD, Mass.–(BUSINESS WIRE)–Aspen Technology, Inc. (NASDAQ:AZPN), a global leader in asset optimization software, has appointed David Leitham as Senior Vice President and General Manager to lead the company’s pharmaceutical industry growth strategy.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210112005156/en/

David Leitham, Senior Vice President and General Manager at Aspen Technology (Photo: Business Wire)

David Leitham, Senior Vice President and General Manager at Aspen Technology (Photo: Business Wire)

Leitham has 25 years’ experience in the pharmaceutical industry and is responsible for expanding AspenTech’s footprint in the pharmaceuticals market, shaping the product and solution strategy and leading go-to-market efforts. He has demonstrated a track record of success integrating and transforming software businesses and products and growing them at double digits, while leading a software portfolio that drove over one billion dollars in connected sales. He brings significant expertise to AspenTech in mergers and acquisitions integration having worked on multiple integration efforts to transform businesses into high performing operations.

Leitham joins AspenTech from Thermo Fisher Scientific, where he was Vice President and General Manager responsible for a team that consistently delivered double-digit growth in software revenue. He also held roles at GlaxoSmithKline, where he served as Vice President, Information Engineering, Technology and Architecture; The Network Connection, where he served as Vice President, Software Engineering and Vice President, Application Development; and FAAC Incorporated, where he held several engineering positions.

“We believe that the pharmaceutical industry can continue to benefit from AspenTech’s current solution portfolio as it increases focus on operational excellence and accelerates its digitalization journey in manufacturing and across the enterprise. We see a significant opportunity to contribute to compliance with the regulatory requirements pharmaceutical companies must meet and to the value creation opportunities available through their ongoing digitalization efforts. Bringing David on board is an important step in helping them achieve these important objectives,” said Antonio Pietri, President and Chief Executive Officer of AspenTech.

“AspenTech has an unrivaled reputation in the process manufacturing industries,” said Leitham. “That reputation has been earned through a relentless focus on meeting the needs of its customers, which I have long shared, and I am looking forward to enhancing that approach, along with our technology and expertise, to the pharmaceutical industry.”

About Aspen Technology

Aspen Technology (AspenTech) is a global leader in asset optimization software. Its solutions address complex, industrial environments where it is critical to optimize the asset design, operation and maintenance lifecycle. AspenTech uniquely combines decades of process modelling expertise with artificial intelligence. Its purpose-built software platform automates knowledge work and builds sustainable competitive advantage by delivering high returns over the entire asset lifecycle. As a result, companies in capital-intensive industries can maximize uptime and push the limits of performance, running their assets safer, greener, longer and faster. Visit AspenTech.com to find out more.

© 2021 Aspen Technology, Inc. AspenTech and the Aspen leaf logo are trademarks of Aspen Technology, Inc.

Aspen Technology, Inc.

Andy Rodger

781-221-4252

[email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Data Management Health Technology Software Networks Pharmaceutical

MEDIA:

Logo
Logo
Photo
Photo
David Leitham, Senior Vice President and General Manager at Aspen Technology (Photo: Business Wire)

Abbott Announces Fulfillment of Federal Government Purchase of 150 Million BinaxNOW™ COVID-19 Rapid Tests and Is Now Ready to Support Commercial Distribution

– Abbott will complete the U.S. government order for 150 million BinaxNOW COVID-19 tests this week and will supply 30 million additional tests through March via a new government order

– Company is in final stages of completing its self-funded capacity expansion across U.S. manufacturing sites

– Abbott has the most advanced and comprehensive COVID-19 rapid test portfolio available today, including ID NOW, BinaxNOW, the BinaxNOW at-home test and the NAVICA app

– Workplaces, universities, schools and other qualified organizations that need frequent and affordable testing can now directly procure BinaxNOW tests from Abbott

PR Newswire

ABBOTT PARK, Ill., Jan. 12, 2021 /PRNewswire/ — Abbott (NYSE: ABT) is announcing today the fulfillment of the federal government’s order of 150 million BinaxNOW COVID-19 Ag tests. These rapid tests were distributed through the Department of Health and Human Services (HHS) to states, territories and targeted entities, such as nursing homes, assisted living facilities, home health and hospice agencies, historically black colleges and universities (HBCUs), and the Indian Health Service.

Abbott is also in the final stages of completing its self-funded investment in U.S. manufacturing capacity and is now ready to make tens of millions of BinaxNOW tests available per month for direct purchase to organizations including schools, workplaces and pharmacies.

“We’ve intentionally developed the most comprehensive COVID testing portfolio and the most advanced family of rapid tests to have the greatest impact we can,” said Robert B. Ford, president and chief executive officer, Abbott. “We’re pleased to take this next step in making BinaxNOW and NAVICA available to support the opening of organizations, and get them to more places where people need them, such as schools and universities, workplaces and pharmacies.”

The University of Wisconsin System will be the first customer in the U.S. to secure BinaxNOW at scale, procuring 480,000 tests over six months for use at its universities and branch campuses.

“The University of Wisconsin System strives to be a national leader in combating COVID-19 and our robust testing strategy is one of our most effective means to do it,” said Tommy Thompson, president, University of Wisconsin System. “We will continue to be aggressive in acquiring and implementing tests at our universities and our partnership with Abbott is key to making this happen.”

At the size of a credit card and with no equipment required, Abbott’s BinaxNOW COVID-19 test – sold directly to qualified organizations for $5 per test – is already the country’s most widely available and mass-produced rapid test, providing results in 15 minutes and detecting the virus when people are most infectious and therefore at the greatest risk of spreading it to others. An at-home, virtually and digitally guided version of the test is also available at $25 per test.

Abbott will continue supplying HHS with a total of 30 million tests between now and March 2021. A breakdown of the initial 150 million tests shipped to states, territories and targeted entities via HHS orders can be found here.

BinaxNOW and NAVICA work together to help organizations perform testing at scale
The BinaxNOW test can be paired with the no-charge NAVICA™ app, which was developed by Abbott to allow people who test negative to display that result through a temporary digital health certificate. People who test negative on BinaxNOW can receive a QR code (similar to a mobile boarding pass used to board an airplane) and organizations can scan and verify the information to manage entry into facilities that accept NAVICA.

“Since October 2020, Abbott has been providing testing for U.S. employees using BinaxNOW and the NAVICA platform. Through the thousands of employees who have been tested, Abbott has gained important insights on managing workflow and how to use NAVICA to allow people to store, access and display their test results,” said Mary Moreland, executive vice president, human resources, Abbott. “Our experience shows that large organizations can effectively manage a high-throughput, rapid testing program across multiple sites and in different occupational settings.”

Since the pandemic began, Abbott has developed the most advanced and comprehensive portfolio of COVID-19 tests across its testing platforms—from high-throughput molecular tests on its m2000 RealTime and Alinity m lab-based systems; to serology tests on its Alinity i  and ARCHITECT® i1000SR and i2000SR instruments; to rapid molecular tests on the ID NOW instrument; to rapid antigen test options on BinaxNOW (available in U.S.) and the Panbio COVID-19 Ag Rapid Test Device (available in countries outside the U.S.).

The company will continue to study the role of testing as more becomes known about the long term efficacy of vaccines and how testing can be deployed to track outbreaks and more confidently return to group settings.

About the BinaxNOW COVID-19 Ag Card Rapid Test
The BinaxNOW COVID-19 Ag Card is an assay for the qualitative detection of specific antigens to COVID-19 in the human nasal cavity. A simple nasal swab is used to collect specimens from people suspected of having an active infection.

Under FDA EUA, the BinaxNOW COVID-19 Ag Card is for use by healthcare professionals and can be used in point-of-care settings that are qualified to have the test performed and are operating under a CLIA (Clinical Laboratory Improvement Amendments) Certificate of Waiver, Certificate of Compliance or Certificate of Accreditation. Within these settings, the test can be performed by doctors, nurses, school nurses, medical assistants and technicians, pharmacists, employer occupational health specialists and more with minimal training and a patient prescription.

About Abbott
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 107,000 colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews.

The BinaxNOW COVID-19 Ag Test Card EUA has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories and patient care settings. The test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. 

 

Cision View original content:http://www.prnewswire.com/news-releases/abbott-announces-fulfillment-of-federal-government-purchase-of-150-million-binaxnow-covid-19-rapid-tests-and-is-now-ready-to-support-commercial-distribution-301205830.html

SOURCE Abbott

BIOLASE Announces Agreement With DSO Dental Care Alliance To Expand Laser Adoption In Dental Offices Across The United States

PR Newswire

FOOTHILL RANCH, Calif., Jan. 12, 2021 /PRNewswire/ — BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers announced an agreement with Dental Care Alliance (DCA), one of the largest dental support organizations (DSO) in the United States with more than 330 affiliated practices in 20 states, to expand laser adoption and hands-on training programs in targeted geographies. The Company expects the agreement to lead to a rollout across all DCA offices in 2021.

“BIOLASE’s’ EpicX™ and Epic Hygiene™ lasers are the standard of care in the dental industry,” said Dr. Don Gallo, Chief Clinical Officer for DCA. “We believe the adoption of this leading technology in our offices will provide a new standard of care for our hygiene appointments, while ensuring a safer environment by reducing aerosolization and addressing early stage periodontal disease.  We are excited about the prospect of providing aerosol-free, less invasive soft tissue procedures, thereby creating a superior patient experience.”

“Our industry leading dental lasers allow us to properly service a customer like DCA, and by reducing aerosols in dental offices we believe we can improve the safety of its office staff and patients,” said Todd Norbe, BIOLASE President and CEO. “The demand for EpicX and Epic Hygiene lasers is rising, and this year alone we have sold over 100 systems to DCA.  We are excited to be partnering with DCA as they continue to roll out our Epic lasers across their U.S. offices.” 

About Dental Care Alliance

Founded in 1991, DCA is one of the largest multi-branded dental support organizations in the U.S. with more than 330 affiliated practices in 20 states. DCA-affiliated practices provide patients with a wide range of dental services including general dentistry, endodontics, oral surgery, orthodontics, pediatric dentistry, and periodontics. DCA provides dentists with clinical autonomy, career satisfaction, and growth opportunities by reducing day-to-day administrative responsibilities so they can focus on providing the best clinical care to each patient.

About BIOLASE, Inc.

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine.  BIOLASE’s products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE’s proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times.  BIOLASE’s innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients.  BIOLASE’s principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications.  BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world.  Laser products under development address BIOLASE’s core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, EpicX™, Epic Hygiene™, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biolase-announces-agreement-with-dso-dental-care-alliance-to-expand-laser-adoption-in-dental-offices-across-the-united-states-301205538.html

SOURCE BIOLASE, Inc.